Merck KGaA’s EMD Serono strikes MFN deal in Trump's fertility treatment pricing push

17th October 2025 Uncategorised 0

Fertility drugmaker EMD Serono, the U.S. arm of Merck KGaA, will offer its in vitro fertilization (IVF) treatments at a sharp discount on the government’s DTC platform TrumpRx.

More: Merck KGaA’s EMD Serono strikes MFN deal in Trump's fertility treatment pricing push
Source: fierce